HBW
HALO icon

Hazlett, Burt & Watson’s Halozyme HALO Stock Holding History

Hazlett, Burt & Watson’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3K Buy
+40
New +$2.82K ﹤0.01% 821

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hazlett, Burt & Watson's HALO Position: Q1 2026 in Review

Hazlett, Burt & Watson opened a new position in Halozyme (HALO) in Q1 2026: 40 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #821 among its holdings.

635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Hazlett, Burt & Watson held 40 shares of Halozyme worth $3K as of Q1 2026.
  • Halozyme was a new Hazlett, Burt & Watson position in Q1 2026.
  • Halozyme made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #821 holding.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.